| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/03/2001 | CA2389522A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 05/03/2001 | CA2389256A1 Beta-defensins |
| 05/03/2001 | CA2389217A1 Mammalian-type glycosylation in plants |
| 05/03/2001 | CA2389196A1 Cyclic peptides and aids vaccines |
| 05/03/2001 | CA2389191A1 Hygromycin derivatives |
| 05/03/2001 | CA2389110A1 Regulation of gene expression by neuroleptic agents |
| 05/03/2001 | CA2389031A1 Dna encoding human alpha1g-c t-type calcium channel |
| 05/03/2001 | CA2388998A1 Treatment of cancer |
| 05/03/2001 | CA2388974A1 Medicament in order to induce tolerance |
| 05/03/2001 | CA2388950A1 Nucleic acids of the human abc1 gene and their therapeutic and diagnostic application |
| 05/03/2001 | CA2388942A1 Therapeutic compositions and methods for treating disease states with mutant forms of myeloid progenitor inhibitory factor-2 (mpif-2) |
| 05/03/2001 | CA2388924A1 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 05/03/2001 | CA2388868A1 Method for pr-39 peptide regulated stimulation of angiogenesis |
| 05/03/2001 | CA2388637A1 Human fgf-20 gene and gene expression products |
| 05/03/2001 | CA2388617A1 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 05/03/2001 | CA2388614A1 Pharmaceutical agent preparations |
| 05/03/2001 | CA2388599A1 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 05/03/2001 | CA2388535A1 Ligand activated transcriptional regulator proteins |
| 05/03/2001 | CA2388514A1 A novel human metabotropic glutamate receptor |
| 05/03/2001 | CA2388338A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 05/03/2001 | CA2388337A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 05/03/2001 | CA2388332A1 Tankyrase h, compositions involved in the cell cycle and methods of use |
| 05/03/2001 | CA2388165A1 Disulfide conjugated cell toxins and methods of making and using them |
| 05/03/2001 | CA2388149A1 Human homologue of yeast helicase and uses thereof |
| 05/03/2001 | CA2388130A1 Molecularly imprinted polymers produced by template polymerisation |
| 05/03/2001 | CA2387921A1 Invasive bacterial vectors for expressing alphavirus replicons |
| 05/03/2001 | CA2387907A1 Serum amyloid a isoform from colostrum |
| 05/03/2001 | CA2387901A1 Salt form of a conjugate useful in the treatment of prostate cancer |
| 05/03/2001 | CA2387897A1 Complex comprising an igfiie polypeptide-fragment and an igfbp2 polypeptide and its use in the treatment of osteoporosis |
| 05/03/2001 | CA2387685A1 Stanniocalcin proteins and nucleic acids and methods based thereon |
| 05/03/2001 | CA2387680A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
| 05/03/2001 | CA2387378A1 Processed human chemokines phc-1 and phc-2 |
| 05/03/2001 | CA2387260A1 Non-anaphylactic forms of grass pollen ph1 p 6 allergen and their use |
| 05/03/2001 | CA2387229A1 Biodegradable microparticles with novel erythropoietin stimulating protein |
| 05/03/2001 | CA2386926A1 Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin |
| 05/03/2001 | CA2386509A1 G protein-coupled receptors expressed in human brain |
| 05/03/2001 | CA2385929A1 Use of gdnf for treating corneal defects |
| 05/03/2001 | CA2361637A1 Porcine b7-1 and antibodies thereto |
| 05/02/2001 | EP1096016A1 Platelet-activating factor acetylhydrolase |
| 05/02/2001 | EP1096009A1 G-protein coupled receptor-like Polypeptide |
| 05/02/2001 | EP1096008A2 Human G protein-coupled receptor, PFI-014 |
| 05/02/2001 | EP1095661A1 Prevention and treatment of biomaterial-associated infections |
| 05/02/2001 | EP1095651A2 Multipor food protection |
| 05/02/2001 | EP1095274A1 Trifunctional reagent for conjugation to a biomolecule |
| 05/02/2001 | EP1095159A1 Bone morphogenic protein |
| 05/02/2001 | EP1095154A2 Interaction of human beta amyloid precursor protein (beta-app) with human lon-protease like protein (hslon) |
| 05/02/2001 | EP1095148A2 Cloning and characterisation of novel mammalian peptidases |
| 05/02/2001 | EP1095143A2 Method for diagnosis and treatment of haemophilia a patients with an inhibitor |
| 05/02/2001 | EP1095142A2 Molecules associated with cell proliferation |
| 05/02/2001 | EP1095140A2 Neurotrophic factors |
| 05/02/2001 | EP1095139A2 Secreted proteins |
| 05/02/2001 | EP1095136A1 Cells and animals deficient in protein kinase c epsilon |
| 05/02/2001 | EP1095133A1 Ftsz multimeric proteins and their uses |
| 05/02/2001 | EP1095061A1 Peptides based on the sequence of human lactoferrin and their use |
| 05/02/2001 | EP1095060A1 Galectin 11 |
| 05/02/2001 | EP1095059A1 Chemotaxis inhibiting protein of staphylococcus (chips) and its use |
| 05/02/2001 | EP1095058A1 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same |
| 05/02/2001 | EP1095057A1 Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives and peptide backbone modified derivatives thereof |
| 05/02/2001 | EP1095038A1 Antagonists of gonadotropin releasing hormone |
| 05/02/2001 | EP1095036A1 Cinnamic acid derivatives as cell adhesion molecules |
| 05/02/2001 | EP1095020A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 05/02/2001 | EP1094863A2 Methods for treating neurological injuries and disorders |
| 05/02/2001 | EP1094849A1 Methods for increasing vascularization and promoting wound healing |
| 05/02/2001 | EP1094835A1 Pharmaceutical composition comprising human apotransferrin and process for manufacturing of the composition |
| 05/02/2001 | EP1094834A1 Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein |
| 05/02/2001 | EP1094833A2 Oxidized thymosin beta 4 |
| 05/02/2001 | EP1094832A1 Therapeutic use of uncoupling protein-hhfcw60 |
| 05/02/2001 | EP1094831A1 Compositions and methods for in vitro fertilization |
| 05/02/2001 | EP1094830A1 USE OF COMPOSITION COMPRISING AT LEAST ONE SUBSTANCE WITHIN THE GROUP GnRH-ANALOGUES FOR TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER (OCD) |
| 05/02/2001 | EP1094829A2 Methods for accelerating bone and cartilage growth and repair |
| 05/02/2001 | EP1094828A1 Use of neglected target tissue antigens in modulation of immune responses |
| 05/02/2001 | EP1094827A1 Prion protein and uses thereof |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 05/02/2001 | EP1094824A1 Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system |
| 05/02/2001 | EP1094810A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 05/02/2001 | EP1094808A1 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone |
| 05/02/2001 | EP1094800A2 PEPTIDYL-PROLYL $i(CIS)-TRANS ISOMERASE INHIBITORS AND USES THEREFOR |
| 05/02/2001 | EP1094787A1 Preparations for protecting infants' skin against diaper dermatitis |
| 05/02/2001 | CN1293712A Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance |
| 05/02/2001 | CN1293710A Mutant recombinant allergens |
| 05/02/2001 | CN1293574A Materials for preventing arteriosclerosis, Immunopotentiating meterials, vertegrates fed with these materials and eggs thereof |
| 05/02/2001 | CN1293568A Lipophilic microparticles containing protein drug or antigen and formulation comprising same |
| 05/02/2001 | CN1293253A Polypeptide-human DPB methyltransferase 41 and polynucleotide for coding this polypeptide |
| 05/02/2001 | CN1293252A Zinc finger protein and polynucleotide sequence for coding it |
| 05/02/2001 | CN1293251A Human ankyrin and polynucleotide sequence for coding it |
| 05/02/2001 | CN1293250A Epidermal growth factor like protein and polynucleotide sequence for coding it |
| 05/02/2001 | CN1293249A Human transmembrane glycosyl transport factor and its coding sequence |
| 05/02/2001 | CN1293248A Human shear and adenylation specific factor protein and its coding sequence |
| 05/02/2001 | CN1293247A Human zinc finger protein and its coding sequence |
| 05/02/2001 | CN1293246A Polypeptide-human calcium ion protein 48 for regulating secretion and polynucleotide for coding this polypeptide |
| 05/02/2001 | CN1293245A Process for separating worm kinase |
| 05/02/2001 | CN1293207A Fusion protein with improved combining activity to target cell receptor |
| 05/02/2001 | CN1293205A Target-specific cytotoxin chimeric with short-peptide harmone |
| 05/02/2001 | CN1293202A Chimeric toxin including modified targeting part |
| 05/02/2001 | CN1065141C Pharmacuetical preparation for administration from nasal mucosa |
| 05/02/2001 | CN1065129C Medicine good for heart |
| 05/01/2001 | US6225457 Polynucleotide sequences associated with bacterial proteins; for detection of bactericides |
| 05/01/2001 | US6225455 Constructs for producing phosphorylated fusion proteins |
| 05/01/2001 | US6225451 Chromosome 11-linked coronary heart disease susceptibility gene CHD1 |
| 05/01/2001 | US6225449 Hormone analogs with multiple CTP extensions |